Mr. Dean Burns reports

OCUMETICS ENGAGES THE HOWARD GROUP TO DIRECT CAPITAL MARKET & CORPORATE DIGITAL COMMUNICATIONS PROGRAMS

Ocumetics Technology Corp. has engaged Howard Group Inc. as its investor relations communications adviser to direct both traditional and on-line initiative targeting institutional and retail investing groups, as well as the broader investment community. The engagement is for six months commencing Sept. 1, 2025, with compensation of $10,000 per month plus additional fees on a fee-for-service basis as required by the company. The company also agreed to grant the Howard Group stock options to purchase up to an aggregate of 250,000 common shares in the share capital of the company for a period of two years at market price when available under the company's stock option plan and to grant an additional 250,000 stock options if the contract is extended for an additional six months. The Howard Group is arm's length to the company.

Engagement of the Howard Group is subject to the approval of the TSX Venture Exchange, which has been sought and is pending.

About Ocumetics Technology Corp.

Ocumetics is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the preclinical study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.

We seek Safe Harbor.